Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for…
Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.
Recover your password.
A password will be e-mailed to you.